Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS)

Curran, C; Vaitaitis, G; Waid, D; Volmer, T; Alverez, E; Wagner, DH

Wagner, DH (通讯作者)，Univ Colorado, Webb Waring Ctr, Anschutz Med Campus, 12850 East Montview Blvd, Aurora, CO 80045 USA.;Wagner, DH (通讯作者)，Univ Colorado, Dept Med, Anschutz Med Campus, 12850 East Montview Blvd, Aurora, CO 80045 USA.

JOURNAL OF NEUROIMMUNOLOGY, 2023; 374 ():

Abstract

Treating MS has been difficult. One successful drug is Ocrelizumab (anti-CD20), used for the chronic relapsing MS (RMS) and the progressive MS (PMS) f......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索